enhancing myosin activation and cardiac contractility: implications for heart failure

18
Activation and Cardiac Contractility: Implications for Heart Failure

Upload: marlon

Post on 23-Feb-2016

42 views

Category:

Documents


0 download

DESCRIPTION

Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure. Heart Failure. Traditional Treatment for Acute Decompensated Heart Failure. Traditional Treatment for Acute Decompensated Heart Failure (cont). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Enhancing Myosin Activation and Cardiac Contractility: Implications for

Heart Failure

Page 2: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Heart Failure

Page 3: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Traditional Treatment for Acute Decompensated Heart Failure

Page 4: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Traditional Treatment for Acute Decompensated Heart Failure

(cont)

Page 5: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Traditional Treatment for Acute Decompensated Heart Failure

(cont)

Page 6: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Traditional Positive Inotropic Agents

Page 7: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Omecamtiv Mecarbil: A Novel Selective Cardiac Myosin

Activator

Page 8: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Omecamtiv Mecarbil

Page 9: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Omecamtiv Mecarbil: Echocardiogram Changes in

Healthy Volunteers

Page 10: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Omecamtiv Mecarbil: Echocardiographic Changes in Patients With Stable Heart Failure

and LV Dysfunction

Page 11: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

ATOMIC-AHF: Study DesignRandomized, Double-blind, Placebo-controlled, Sequential

Cohort Study

Page 12: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

ATOMIC-AHF-Primary End Point:Dyspnea Response

Paired Placebo

Page 13: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Safety Concerns

Page 14: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Supraventricular and Ventricular Tachyarrhythmias

Page 15: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

COSMIC-HF: Chronic Oral Study of Myosin Activation to

Increase Contractility in Heart Failure

Page 16: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

References

Page 17: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Abbreviations

Page 18: Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

Abbreviations (cont)